Elevated circulating level of beta-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors.
Katano S, Yano T, Kouzu H, Nagaoka R, Numazawa R, Yamano K, Fujisawa Y, Ohori K, Nagano N, Fujito T, Nishikawa R, Ohwada W, Katayose M, Sato T, Kuno A, Furuhashi M.
Katano S, et al.
Cardiovasc Diabetol. 2022 Dec 20;21(1):285. doi: 10.1186/s12933-022-01727-x.
Cardiovasc Diabetol. 2022.
PMID: 36539818
Free PMC article.
Analyses in patients in whom plasma BAIBA was detected showed that plasma BAIBA concentration was significantly higher in patients receiving an SGLT2i than in patients not receiving an SGLT2i (6.76 4.72 vs. 4.56 2.93 nmol/ml, p = 0.03). ...CONCLUSION: SGLT2i use is …
Analyses in patients in whom plasma BAIBA was detected showed that plasma BAIBA concentration was significantly higher in pati …